| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 12/24/2008 | CN100445300C GLP-1 fusion protein and its preparation method and medicinal uses |
| 12/24/2008 | CA2691386A1 Biological active proteins having increased in vivo and/or in vitro stability |
| 12/24/2008 | CA2691091A1 Fusion protein, macromolecule assembled from the fusion protein, and its use in the prevention or treatment of human papillomavirus related diseases |
| 12/24/2008 | CA2691033A1 Capsid proteins and uses therefore |
| 12/23/2008 | US7468352 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 12/23/2008 | CA2105300C Process for the development of binding mini-proteins |
| 12/18/2008 | WO2008152655A1 Anthrax fusion proteins, compositions and uses thereof |
| 12/18/2008 | WO2008152654A1 Anthrax fusion proteins, compositions and uses thereof |
| 12/18/2008 | WO2008151440A1 Modifying glycoprotein production in plants |
| 12/18/2008 | WO2008151405A1 Expression of fusion proteins containing a single chain antibody fragment linked to elastin-like repeating units in transgenic plants |
| 12/18/2008 | WO2008118849A3 Hiv-1 protease inhibitors |
| 12/18/2008 | WO2007141650A3 Compositions and methods for diagnosing hiv-2 infection |
| 12/18/2008 | US20080312421 Use of A33 antigens and JAM-it |
| 12/18/2008 | US20080312412 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines |
| 12/18/2008 | US20080312410 Cysteine-containing peptide tag for site-specific conjugation of proteins |
| 12/18/2008 | US20080311655 Heterodimeric fusion protein for use in the treatment of allergies and metastatic disease; cytokine linked to an antibody; nucleic acid encoding a fusion protein comprising an immunoglobulin (Ig) moiety linked by a peptide bond to the p35 subunit of interleukin-12 |
| 12/18/2008 | US20080311624 Chimeric immunogens |
| 12/18/2008 | US20080311622 Activatable recombinant neurotoxins |
| 12/18/2008 | US20080311621 Polypeptides and nucleic acids encoding same |
| 12/18/2008 | US20080311137 Carcinoembryonic Antigen Fusions and Uses Thereof |
| 12/18/2008 | US20080311132 Human Complement C3 Derivates with Cobra Venom Factor-Like Function |
| 12/18/2008 | US20080311124 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/18/2008 | US20080311123 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/18/2008 | US20080311121 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/18/2008 | US20080311106 Product Comprising a C4bp Core Protein and a monomeric Antigen, and Its Use |
| 12/18/2008 | CA2840407A1 Compositions and methods for producing bioactive fusion proteins |
| 12/18/2008 | CA2700180A1 Modifying glycoprotein production in plants |
| 12/17/2008 | EP2001908A2 Fusion proteins between plant cell-wall degrading enzymes and a swollenin, and their uses |
| 12/17/2008 | EP2001907A2 Methods and compositions for antagonism of rage |
| 12/17/2008 | EP1007696B1 Il-13 receptor specific chimeric proteins and uses thereof |
| 12/17/2008 | CN101323644A Recombinant cecA-mil heterozygous gene antibiotic peptides |
| 12/17/2008 | CN101323643A Optimized TACI-Fc fuse protein |
| 12/17/2008 | CN100443503C Humanized CTLA-4 single chain antibody and human perforin path formed peptide P34 recombinant immunotoxin |
| 12/16/2008 | US7465705 Immunogenic Nogo receptor-1 polypeptides, Nogo receptor-1 antibodies; diabetic neuropathy; brain injury, spinal cord injury |
| 12/16/2008 | US7465550 Method for screening taste-modulating compounds |
| 12/16/2008 | CA2449071C Chimaeric phages |
| 12/16/2008 | CA2285667C Viral vectors having chimeric envelope proteins containing the igg-binding domain of protein a |
| 12/16/2008 | CA2284397C Amino acid modified polypeptides |
| 12/11/2008 | WO2008148881A1 The puro-dhfr quadrifunctional marker and its use in protein production |
| 12/11/2008 | WO2008148223A1 Nanocarrier based plant transfection and transduction |
| 12/11/2008 | WO2008101671A3 Il-4 fc fusion proteins |
| 12/11/2008 | WO2008069965A3 Novel genes and proteins that home to developing microvessels |
| 12/11/2008 | WO1999027105A9 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 12/11/2008 | US20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same |
| 12/11/2008 | US20080305542 G protein coupled receptor (GPCR) polypeptide, attached to a detectable label seleacted from green fluorescent polypeptide or a rhodopsin polypeptide, involved in bitter taste transduction; used as additives for foods, beverages and drugs in order to modify T2R-associated bitter taste |
| 12/11/2008 | US20080305101 Methods and Compositions Related to Clot Binding Compounds |
| 12/11/2008 | CA2693525A1 Nanocarrier based plant transfection and transduction |
| 12/11/2008 | CA2689317A1 Antigen presenting cells |
| 12/11/2008 | CA2687538A1 The puro-dhfr quadrifunctional marker and its use in protein production |
| 12/10/2008 | EP2000536A2 Tat-derived transport polypeptides |
| 12/10/2008 | EP2000483A2 Vegf receptor fusion protein and use thereof |
| 12/10/2008 | EP1999261A2 The use of protein s fusion for protein solubilization |
| 12/10/2008 | EP1289549B1 The use of plant oil-bodies in vaccine delivery systems |
| 12/10/2008 | EP1220915B1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 12/10/2008 | EP1163342B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/10/2008 | EP1074564B1 Substance with antithrombotic activity and method for detecting glycokallidin |
| 12/10/2008 | EP0972054B1 Enhancement of immune response using targeting molecules |
| 12/10/2008 | CN101321870A Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 12/10/2008 | CN101321777A Silk proteins |
| 12/10/2008 | CN101319012A Calcitonin-gene-related peptide and trout calcitonin amalgamation polypeptide |
| 12/10/2008 | CN101319011A Multi-type HCV-E1 epitope complex immunogen, encoding gene and application thereof |
| 12/10/2008 | CN100441223C Human papilloma virus treatment |
| 12/09/2008 | US7462462 Peptide capable of binding to nanographite structures |
| 12/09/2008 | US7462357 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants |
| 12/09/2008 | US7462350 cytokine fusion proteins with an increased therapeutic index; able to bind to more than one type of cytokine receptor expressed on cells |
| 12/09/2008 | CA2215203C Vaccines for plague |
| 12/09/2008 | CA2202652C Production of peptides in plants as viral coat protein fusions |
| 12/09/2008 | CA2202504C Chimeric conformational epitope peptides |
| 12/04/2008 | WO2008147143A2 Immunoglobulin fusion proteins |
| 12/04/2008 | WO2008146707A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof |
| 12/04/2008 | WO2008145951A1 Protein layers and their use in electron microscopy |
| 12/04/2008 | WO2008145830A2 Novel pro-fluorescent compounds |
| 12/04/2008 | WO2008145013A1 Fusion protein comprising targeting peptide of cd13 and lidamycin |
| 12/04/2008 | WO2008144817A1 Fluorescent protein particles |
| 12/04/2008 | US20080300187 Mutated hoxb4 proteins with improved stability, and methods of use thereof |
| 12/04/2008 | US20080299618 Single domain ligands, receptors comprising said ligands, methods for their production and use of said ligands and receptors |
| 12/04/2008 | US20080299596 Substrates and assays for beta-secretase activity |
| 12/04/2008 | US20080299547 Novel stra6 polypeptides |
| 12/04/2008 | US20080299142 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 12/04/2008 | US20080299134 Recombinant Anti-Interleukin-9 Antibodies |
| 12/04/2008 | US20080299120 Multivalent antibodies and uses therefor |
| 12/04/2008 | US20080299119 Polypeptides homologous to vegf and bmp1 |
| 12/04/2008 | DE102007025291A1 Verfahren und Immunabsorbentien zur spezifischen Detektion und Absorption Zöliakie- und Dermatitis herpetiformis assoziierter Antikörper Procedures and immunoabsorbents for the specific detection and absorption celiac disease and dermatitis herpetiformis associated antibodies |
| 12/04/2008 | CA2688557A1 Fluorescent protein particles |
| 12/04/2008 | CA2687908A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof |
| 12/04/2008 | CA2687377A1 Immunoglobulin fusion proteins |
| 12/03/2008 | EP1998266A2 Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 12/03/2008 | EP1997894A2 Biosynthetic binding protein for cancer marker |
| 12/03/2008 | EP1997891A1 Generation and selection of recombinant varied binding proteins |
| 12/03/2008 | EP1997829A1 Albumin fusion proteins |
| 12/03/2008 | EP1997512A2 Methods for treating TWEAK-related conditions |
| 12/03/2008 | EP1996230A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 12/03/2008 | EP1380592B1 Cell surface layer-binding protein and utilization thereof |
| 12/03/2008 | EP0606217B2 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 12/03/2008 | CN101314619A Tumour treatment vaccine CTP37CRM197 immunogen, preparation method and application thereof |
| 12/03/2008 | CN101314036A Genetic engineering polypeptide vaccine against livestock foot and mouth disease virus, and preparation method thereof |
| 12/03/2008 | CN100439395C Compositions and methods for therapy and diagnosis of ovarian cancer |
| 12/03/2008 | CN100439394C Pharmaceutical use for secreted bacterial effector proteins |
| 12/03/2008 | CN100439391C Process for producing hydrophobic polypeptides, proteins or peptides |
| 12/02/2008 | US7459544 Comprises nucleotide sequences coding b lymphocyte antigens for use as tool in prevention and treatment of cell proliferative disorders; immunotherapy |